Comparative Pharmacology
Head-to-head clinical analysis: CALCIUM CHLORIDE 10 IN PLASTIC CONTAINER versus HEMICLOR.
Peer-Reviewed Evidence
Head-to-head clinical analysis: CALCIUM CHLORIDE 10 IN PLASTIC CONTAINER versus HEMICLOR.
CALCIUM CHLORIDE 10% IN PLASTIC CONTAINER vs HEMICLOR
Comparing the clinical profiles, pharmacokinetic behaviors, and safety indices of these two therapeutic agents.
Calcium ion is essential for normal cell function, including muscle contraction, nerve transmission, and blood coagulation. It acts as a positive inotrope by increasing myocardial contractility and also corrects hypocalcemia.
Hemichlor (HEMICLOR) is a brand name for a combination product containing chlorpheniramine and pseudoephedrine. Chlorpheniramine is a first-generation antihistamine that antagonizes histamine at H1 receptor sites, reducing allergic symptoms. Pseudoephedrine is a sympathomimetic amine that directly stimulates alpha-adrenergic receptors, causing vasoconstriction and decongestion.
IV: 500 mg to 1 g (5-10 mL of 10% solution) administered slowly at a rate not exceeding 0.5-1 mL/min. May be repeated as needed based on serum calcium levels and clinical response.
50-100 mg intravenously every 6 hours or 100 mg orally every 12 hours.
None Documented
None Documented
2-4 hours in patients with normal renal function; prolonged in renal impairment.
Terminal elimination half-life 18–24 hours in normal renal function; prolonged to 36–48 hours in moderate renal impairment (CrCl 30–50 mL/min); adjust dosing interval in renal disease.
Primarily renal (80-90% as ionized calcium); minor fecal elimination (<10%).
Primarily renal (85–90% as unchanged drug via glomerular filtration and tubular secretion); biliary/fecal < 5%.
Category C
Category C
Electrolyte Supplement
Electrolyte Supplement